Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Judith de Vos-Geelen

Maastricht University Medical Centre

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

30%

Clinical Nutrition

40%

Oncology

70%

Pancreatic Cancer

40%

Gastrointestinal Surgery

40%

Pancreatic Surgery

30%

Intestinal Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon

Article Link

Year:

2024

Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment

Article Link

Year:

2024

ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial

Article Link

Year:

2024

Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database

Article Link

Year:

2023

Nationwide evaluation of pancreatic cancer networks ten years after the centralization of pancreatic surgery

Article Link

Year:

2023

Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival

Article Link

Year:

2023

Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer

Article Link

Year:

2023

Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer

Article Link

Year:

2023

Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database

Article Link

Year:

2023

Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival

Article Link

Year:

2023

The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine

Article Link

Year:

2022

PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma

Article Link

Year:

2022

Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A nationwide analysis

Article Link

Year:

2022

Age and prognosis in patients with pancreatic cancer: a population-based study

Article Link

Year:

2022

Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls

Article Link

Year:

2021

Collaborators10

Zoltan Czigany

GERMANY

Sander Rensen

Associate professor

University of Maastricht

NETHERLANDS

Martijn W J Stommel

Radboud University Medical Center

NETHERLANDS

Janine Ziemons

University of Maastricht

NETHERLANDS

Sven Arke Lang

University Hospital Essen

GERMANY

Nadine Gaisa

RWTH Aachen University

GERMANY

John Penders

Associate professor

University of Maastricht

NETHERLANDS

David Barnett

University of Maastricht

NETHERLANDS

Robin van geel

University of Maastricht

NETHERLANDS

Ardy van Helvoort

Associate Professor

University of Maastricht

NETHERLANDS

How do I reach out?

Meet Kite AI